Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatin

C Lanvers-Kaminsky, G Ciarimboli - Pharmacogenomics, 2017 - Future Medicine
Aminoglycosides and the anticancer drug cisplatin can cause permanent hearing loss,
which impacts patients' quality of life and results in considerable subsequent costs. Since …

Polymorphic Variation in TPMT Is the Principal Determinant of TPMT Phenotype: A Meta‐Analysis of Three Genome‐Wide Association Studies

R Tamm, R Mägi, R Tremmel, S Winter… - Clinical …, 2017 - Wiley Online Library
Thiopurine‐related hematotoxicity in pediatric acute lymphoblastic leukemia (ALL) and
inflammatory bowel diseases has been linked to genetically defined variability in thiopurine …

[HTML][HTML] Transcriptional signature of lymphoblastoid cell lines of BRCA1, BRCA2 and non-BRCA1/2 high risk breast cancer families

MC Pouliot, C Kothari, C Joly-Beauparlant, Y Labrie… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Approximately 25% of hereditary breast cancer cases are associated with a strong familial
history which can be explained by mutations in BRCA1 or BRCA2 and other lower …

Methods to analyze big data in pharmacogenomics research

R Li, D Kim, MD Ritchie - Pharmacogenomics, 2017 - Future Medicine
The scale and scope of pharmacogenomics research continues to expand as the cost and
efficiency of molecular data generation techniques advance. These new technologies give …

DNA methylation of a novel PAK4 locus influences ototoxicity susceptibility following cisplatin and radiation therapy for pediatric embryonal tumors

AL Brown, KL Foster, PJ Lupo… - Neuro …, 2017 - academic.oup.com
Background Ototoxicity is a common adverse side effect of platinum chemotherapy and
cranial radiation therapy; however, individual susceptibility is highly variable. Therefore, our …

Rethinking ovarian cancer genomics: where genome-wide association studies stand?

R Pinto, J Assis, A Nogueira, C Pereira… - …, 2017 - Future Medicine
Genome-wide association studies (GWAS) allow the finding of genetic variants associated
with several traits. Regarding ovarian cancer (OC), 15 GWAS have been conducted since …

医学大数据在药物基因组学领域中的应用与发展

孙可欣, 詹思延, 胡永华 - 药物流行病学杂志, 2017 - cqvip.com
随着药物基因组学研究的不断发展, 医学大数据在药物基因组学领域中的应用越来越多.
本文从建立大型药物基因组学数据库, 借助电子健康档案与基因分型数据库开展药物基因组学 …

[HTML][HTML] 表达数量性状位点分析在药物基因组学中的应用

陈长仁, 何发忠, 刘谋泽, 周宏灏, 张伟 - 药学学报, 2017 - html.rhhz.net
在全基因组关联分析(GWAS) 时代发现的大量药物应答相关位点位于非编码序列,
对其机制解释多关注于这些位点对mRNA 表达水平的影响. 表达数量性状位点(expression …

Evaluating the association of multiple single nucleotide polymorphisms with response to gemcitabine and platinum combination chemotherapy in urothelial carcinoma …

S Alanee, S Shah, E Zabor, J Vijai… - … journal of clinical …, 2017 - search.proquest.com
Objective: To examine germline single nucleotide polymorphisms (SNPs) as markers of
response to gemcitabine platinum (GP) combination chemotherapy in urothelial carcinoma …

[PDF][PDF] Genome-wide association studies and clinical outcome in ovarian cancer patients: validation in an independent cohort

RJC Pinto - 2017 - repositorio-aberto.up.pt
Durante esta etapa da minha vida académica que agora termina, tive a oportunidade de
alargar os meus conhecimentos numa área de eleição, assim como de crescer a nível …